Stock AnalizGE HealthCare Technologies Inc. GEHC
Medical Electronics · data as of November 13, 2026
GE HealthCare Technologies Inc. (GEHC) is a healthcare company listed in the US with a market value of about $37.5B. In the twelve months to September 30, 2026 it had revenue of $21.6B and net income of $2.2B, a net margin of 10.0%.
Its overall Stock Analiz score is 2.4 out of 5 (weak). The strongest part is value (3/5); the weakest is future growth (2/5).
Key numbers: a P/E of 17.5, a price to free cash flow of 19.9, a 5-year average ROIC of 11%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 26% below the current price.
Score: 2.4 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Profit margin improving
- Strong R&D investment or growth above 20%
- Profitable 5 years in a row
- ROE above 15%
- Positive free cash flow
Checks not passed
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 5 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $21.6B | $20.6B | $19.7B | $19.6B | $18.3B | $17.6B |
| Net income | $2.2B | $2.1B | $2.0B | $1.6B | $1.9B | $2.2B |
| Free cash flow | $1.9B | $1.5B | $1.6B | $1.7B | $1.8B | $1.4B |
| EPS (diluted) | $4.74 | $4.55 | $4.34 | $3.03 | $4.22 | $4.95 |
| Net margin | 10.0% | 10.1% | 10.1% | 8.0% | 10.4% | 12.8% |
| ROIC | — | 10.3% | 11.7% | 9.8% | 10.9% | 13.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 20 analysts is $87.85, 6% above the current price; targets range from $75.00 to $100.00; the consensus rating is “Buy”; expected EPS is $5.02 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is GE HealthCare Technologies’s P/E ratio?
About 17.5, based on the last twelve months of diluted earnings per share (forward P/E about 15.3).
Is GE HealthCare Technologies stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 26% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does GE HealthCare Technologies pay a dividend?
Yes. The dividend yield is about 0.19%, and it has paid dividends for 3 years in our data.
Is GE HealthCare Technologies a good stock to buy?
We do not give buy or sell advice. GE HealthCare Technologies scores 2.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.